HLB Co., Ltd. (KOSDAQ:A028300) entered into a contract to acquire 18.4% stake in KNOTUS Co.,Ltd (KOSDAQ:A278650) from Jeong In-seong and Kim Do-hyung for KRW 56.2 billion on December 27, 2021. As per the transaction, HLB Co., Ltd. will acquire 1,405,648 shares of KNOTUS Co.,Ltd at KRW 40,000 per share. The transaction is expected to complete on March 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,475 KRW | -2.80% | -2.66% | +12.46% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.46% | 219M | |
-27.67% | 9.87B | |
-17.30% | 2.74B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+59.69% | 1.39B | |
+23.58% | 771M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M |
- Stock Market
- Equities
- A278650 Stock
- News HLB bioStep Co.,Ltd.
- HLB Co., Ltd. entered into a contract to acquire 18.4% stake in KNOTUS Co.,Ltd from Jeong In-seong and Kim Do-hyung for KRW 56.2 billion.